Clinical Trial Update: Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis [Phase 2]

View source ↗

Summary

An open-label Phase 2 study of HTD1801 in adults with primary biliary cholangitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Stricture
• Biliary Cholangitis
• Biliary Cirrhosis
• Biliary Tract Diseases
• Cholangitis
• Cholestasis

Drugs mentioned

• HTD1801

Snippet

Sponsor: HighTide Biopharma Pty Ltd | Conditions: Primary Biliary Cholangitis, Primary Biliary Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2024-04-24